MacroGenics
MGNX
#8291
Rank
A$0.37 B
Marketcap
A$5.87
Share price
-3.88%
Change (1 day)
171.45%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.37 Billion

As of May 2026 MacroGenics has a market cap of A$0.37 Billion. This makes MacroGenics the world's 8291th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.37 B145.49%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On May 27th, 2026 the market cap of MacroGenics was reported to be:

A$0.38 Billion
by Nasdaq info icon info icon
A$0.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$207.81 B 55,573.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.401 T 375,390.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$253.31 B 67,762.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$235.91 B 63,101.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$413.03 B 110,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$162.10 B 43,328.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.23 B 231.64%๐Ÿ‡บ๐Ÿ‡ธ USA